SCHEMBL7378658

SCHEMBL7378658

O=C(O)C1(c2nc3ccccc3o2)CCCO1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 1/20 0.51
ITGA4 P13612 1/20 0.51
ITGB7 P26010 1/20 0.51
LMNA P02545 2/20 0.39
GAA P10253 2/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KDM4E B2RXH2 1/20 0.39
HTT P42858 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM5 P08912 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
KDM1A O60341 1/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3104444 0.76 CHRM2 (0.43) LMNAGAAMAPTCYP2C9CYP2C19
SCHEMBL4829823 0.74 AKR1C1 (0.48) ITGB1ITGA4ITGB7LMNAALDH1A1
SCHEMBL20581835 0.70 RAB9A (0.43) LMNAGAAMAPTALDH1A1KDM4E
SCHEMBL10848298 0.69 AKR1C1 (0.52) ITGB1ITGA4ITGB7LMNAALDH1A1
SCHEMBL13342378 0.69 ALDH1A1 (0.49) ITGB1ITGA4ITGB7LMNAMAPT
SCHEMBL25172246 0.67 CHRM2 (0.47) LMNAGAACYP2C9CYP2C19ALDH1A1
SCHEMBL24780850 0.66 ITGB1 (0.44) ITGB1ITGA4ITGB7LMNAMAPT
SCHEMBL25473611 0.66 ITGB1 (0.44) ITGB1ITGA4ITGB7LMNAMAPT
SCHEMBL25171918 0.66 DPP4 (0.45) LMNAGAACYP2C9CYP2C19ALDH1A1
SCHEMBL12561523 0.66 RAB9A (0.42) ITGB1ITGA4ITGB7MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420418-B1 INHIBITION AND PREVENTION OF LEUKOCYTE ADHESION; USED TO TREAT ADHESION-MEDIATED DISEASES SUCH AS ASTHMA, ALLERGIC RHINITIS, MULTIPLE SCLEROSIS; ATHEROSCLEROSIS, AND INFLAMMATORY BOWEL DISEASE MERCK & CO., INC. 2002-07-16 US disclosed
WO-2001012183-A1 HETEROCYCLE AMIDES AS CELL ADHESION INHIBITORS MERCK & CO., INC. (US) 2001-02-22 WO disclosed